Revenue and net profit grew year-over-year for both standalone and consolidated results in Q2 and H1 FY26. Key subsidiaries received regulatory approvals, and IPO proceeds were utilized as planned with no deviations.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.